TrialAnnals of hematology2024

Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study.

Hongbing Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.